Ad is loading...
GSAOX vs VEXRX
GSAOX vs VEXRX Comparison
Open Charts GSAOX vs VEXRX
Goldman Sachs Small Cap Gr Insghts A
Price$14.20
Change+$0.28 (+2.01%)
VolumeN/A
Net Assets113.54M
GSAOX vs VEXRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
GSAOX vs. VEXRX commentary
Apr 25, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSAOX is a Buy and VEXRX is a Buy.
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 19.8B vs. GSAOX (114M). GSAOX pays higher dividends than VEXRX: GSAOX (1.12) vs VEXRX (0.56). GSAOX was incepted earlier than VEXRX: GSAOX (18 years) vs VEXRX (23 years). GSAOX (1.43) is less costly to investors than VEXRX (0.34). GSAOX is a more actively managed with annual turnover of: 166.00 vs. VEXRX (35.00). GSAOX has a lower initial minimum investment than VEXRX: GSAOX (1000) vs VEXRX (50000). GSAOX annual gain was more profitable for investors over the last year : -0.98 vs. VEXRX (-12.82). VEXRX return over 5 years is better than : 15.80 vs. GSAOX (-50.56).
| GSAOX | VEXRX | GSAOX / VEXRX | |
| Total Expense Ratio | 1.21 | 0.34 | 356% |
| Annual Report Gross Expense Ratio | 1.43 | 0.34 | 421% |
| Fund Existence | 18 years | 23 years | - |
| Gain YTD | -16.296 | -14.722 | 111% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 50000 | 2% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 114M | 19.8B | 1% |
| Annual Yield % from dividends | 1.12 | 0.56 | 198% |
| Returns for 1 year | -0.98 | -12.82 | 8% |
| Returns for 3 years | 12.37 | -9.40 | -132% |
| Returns for 5 years | -50.56 | 15.80 | -320% |
| Returns for 10 years | -57.74 | -1.76 | 3,274% |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XBI | 79.10 | 1.46 | +1.88% |
| SPDR® S&P Biotech ETF | |||
| CHI | 9.78 | 0.17 | +1.77% |
| Calamos Convertible Opportunities and Income Fund | |||
| SBIO | 28.02 | 0.45 | +1.63% |
| ALPS Medical Breakthroughs ETF | |||
| BCDF | 28.54 | 0.12 | +0.44% |
| Horizon Kinetics Blockchain Dev ETF | |||
| FEP | 41.67 | -0.06 | -0.14% |
| First Trust Europe AlphaDEX® ETF | |||